Cargando…
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in people with cystic fibrosis (pwCF) can lead to severe outcomes. METHODS: In this observational study, the European Cystic Fibrosis Society Patient Registry collected data on pwCF and SARS-CoV-2 infection to estimat...
Ejemplares similares
-
Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020
por: Naehrlich, Lutz, et al.
Publicado: (2021) -
Risk factors for forced expiratory volume in 1 s decline in European patients with cystic fibrosis: data from the European Cystic Fibrosis Society Patient Registry
por: Hatziagorou, Elpis, et al.
Publicado: (2023) -
The European Cystic Fibrosis Society Patient Registry: valuable lessons learned on how to sustain a disease registry
por: Viviani, Laura, et al.
Publicado: (2014) -
Therapeutic Approaches for Patients with Cystic Fibrosis Not Eligible for Current CFTR Modulators
por: Fajac, Isabelle, et al.
Publicado: (2021) -
Association of Oxygen Therapy with the Natural Disease Progression of Cystic Fibrosis: A Multi-State Model of the European Cystic Fibrosis Society Patient Registry
por: Gambazza, Simone, et al.
Publicado: (2023)